CureSkin Reports ₹133 Cr Revenue in FY26, Slashes Net Loss to ₹35 Cr

Bengaluru: AI-powered dermatology and skincare platform CureSkin posted a 27.9% increase in operational revenue for FY26, touching ₹133 crore compared to ₹104 crore in FY25. Alongside top-line growth, the Bengaluru-based company drastically improved its bottom line, trimming its net loss by 48.5% to ₹35 crore from ₹68 crore in the previous financial year. Including ₹1 crore in other income, total revenue for the fiscal stood at ₹134 crore.

The financial improvement was anchored by strong direct sales and improved marketing efficiency. Product sales remained the central growth driver, generating ₹120.6 crore and accounting for roughly 91% of operating revenue. Services revenue also witnessed rapid adoption, rising nearly ninefold to ₹12.4 crore. On the cost front, CureSkin cut its advertising and promotional expenditure by 17.6% to ₹61 crore from ₹74 crore in FY25, substantially lowering one of its biggest burn heads.

The combination of higher sales and disciplined marketing spending enabled CureSkin to strengthen its operating leverage. Expenditure per rupee of operating revenue declined to ₹1.27 from ₹1.69 in FY25, while the company’s EBITDA margin improved to -21.81% from -60.94%. Backed by investors including HealthQuad, JSW Ventures, Khosla Ventures, and Sharrp Ventures, the $26 million funded startup reported cash and bank balances of ₹8 crore and current assets of ₹40 crore as of March 2026.